Navigation Links
Thanatophoric Dysplasia Type II, Fetal

ProductsThanatophoric Dysplasia Type II, Fetal
Company ARUP Laboratories
Item Thanatophoric Dysplasia Type II, Fetal
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Thanatophoric Dysplasia Type II
2. FetalSAT™
3. Achondroplasia Mutation, Fetal
4. APT Test-Fetal Hemoglobin
5. Beta Globin Sequencing, Fetal
6. Chromosome Analysis, Fetal Blood
7. Cystic Fibrosis, Mutation Panel, Fetal
8. Factor V Leiden, Fetal
9. Fetal Fibronectin
10. Fetal Hemoglobin Determination for Fetomaternal Hemorrhage
11. Fetal Hemoglobin (Hemoglobin F)
The Nevyas Drape Support is the simple and inexpensive way to establish a zone of comfort for your patients during ophthalmic surgery which requires draping over the nose and mouth. Packaged in sets
The Multi-Cap system provides patients with the ability to quickly change from distance viewing to reading. The telescope has a magnification of 1.75x for distance viewing. The double lens caps are
The longer working distances achieved by the use of Galilean optics make this the perfect magnifier to enable the patient to read and write.
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame.
Medicine Products:
(Date:12/3/2008)... ECPI College of Technology ...South Carolina veterans who have served in Iraq or...ly introduced in fall 2005 and is also available t...have served in these regions. Up to $150,000 in sc...sses at ECPI College of Technology or Medical Care...
(Date:12/3/2008)...CAGO, Dec. 3 The Americ...Institute of Medicine (IOM) for its committee repo...ember 2, 2008, by the IOM Committee on Optimizing ... Schedules to Improve Patient Safety. , , ...rther reductions in the mandated 80-hour work week...
(Date:12/3/2008)...CAGO, Dec. 3 Breast-Specific Gamma...tter specificity than breast MRI in patients with,...sound in the diagnosis of,breast cancer, accordin...g of,the Radiological Society of North America (R...e used as an adjunctive tool to mammography that c...
(Date:12/3/2008)...dy suggests need to change therapeutic guidelines,...s) -- A pill that contains two blood pressure drug...y in reducing the risk of serious cardiovascular p...re, according to a study that included more than 1...y, Denmark and Finland. , The patients took eit...
Breaking Medicine News(10 mins):Health News: ECPI College of Technology and Medical Careers Institute Announce Extension for South Carolina Military Scholarship Opportunity 2Health News:American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours 2Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2Health News:Blood Pressure Pill Combo More Effective Than Diuretics 2
...n to provide health insurance to around 1.2 millio...ister H.D. Kumaraswamy announced// here Wednesday....onomic backwardness of thousands of families. We h...e to BPL families, and Rs.350 million (Rs.35 crore...
...th weakened immune systems should not eat raw// or... Canadians by Health Canada. “Eat veggies full of...uliflower and green beans help to keep us strong, ...by a mother, but not recently, certain varieties o...
...ssue of the Cochrane Library journal concludes //t...tion (ED) - Cialis, Levitra and Viagra appear to b...drugs are included in a family of medications call...hibitors. Diabetes is one of the main causes of E...
...h has awarded a three-year $2.1 million grant to r...ago to develop a new drug to treat bipolar disorde... to enter the brain and block the mania associated...stigator Alan Kozikowski, professor of medicinal c...
Other Medicine News:Health News:Karnataka's Free Health Insurance to the Poor 2Health News:Raw (or) Undercooked Sprouts May Carry Harmful Bacteria 2Health News:ED Drugs - Safe and Effective for Diabetic Men 2Health News:UIC Researchers Receive $2.1 Million Grant 2
(Date:12/2/2008).... 2 Biopure Corporation,...aval Medical Research Center,(NMRC) has submitted...ed,investigational new drug (IND) application to ...therapeutic Hemopure(R) [hemoglobin glutamer - 250...ment of trauma patients. The study is,entitled "O...
(Date:12/2/2008)... Horizon Therapeutics, Inc., a,pri...nced that two pivotal,Phase 3 trials evaluating i...,met all primary endpoints. HZT-501, a novel, pr...ng ibuprofen and famotidine, demonstrated a,stati... non-steroidal,anti-inflammatory drug (NSAID)-ind...
(Date:12/1/2008)...CAGO, Dec. 2 A study ha...a new technique for imaging the breast, is not aff...al status, two factors that limit the effectivenes...cer. Results will be presented today at the annual...ica (RSNA). , , "The ability of PEM to det...
(Date:12/1/2008)...Newswire/ -- S*BIO Pte Ltd today announced the ini... potent and orally-active JAK2 inhibitor, in leadi...chronic idiopathic myelofibrosis (CIMF). , ,...d tolerability of SB1518 in patients with CIMF and...e 1 part of the study will assess the safety profi...
Breaking Medicine Technology:U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 1FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 2Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 1Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 2Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 3Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 4Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 5Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 1Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 3Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day 2011 1